ClinicalTrials.gg
CompletedNCT06378372Updated Nov 13, 2026

How Does Pianistic Musical Training Influence the Development of Alzheimer's Disease?

An interventional study of Music therapy based on piano learning in Dementia of Alzheimer Type, Dementia and Dementia, Vascular, sponsored by David Franco Castellanos. Completed at 1 site in Spain. Open to participants aged 50 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by David Franco Castellanos · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 13, 2026Now CompletedStart date moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
50 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 114 studies in Dementia with a site in Spain — 27 open to participants now, 37 under way, 9 of them phase 3. Dementia · Spain.

Enrollment
94th of 95
5 · median 240
Started
2024
with 9 others
No phase
36 of 114
10 open now
Registered
92nd of 114
by date

Among the 114 studies in Dementia with a site in Spain, this one is the 94th largest by enrollment of the 95 interventional ones that give a count, is one of 10 that started in 2024, is one of 36 with no phase, and was the 92nd registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

27 of the 114 studies in Dementia with a site in Spain are open now. Recruiting first, the newest first:

22 more — sign in →

All 27 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 50 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 114 studies in Dementia with a site in Spain, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn about and describe how pianistic training influences the development of Alzheimer's disease.

The key question is: Can pianistic practice influence the development of Alzheimer's disease?

Participants will receive piano lessons for 4 weeks (20 sessions) and we will evaluate the evolution of the different parameters described by the tests carried out.

Read the detailed description

Alzheimer's disease (AD) is a chronic neurodegenerative disease that affects different areas of the brain causing progressive changes in behavior, memory loss, decreased personal autonomy and various cognitive alterations. (Masters et al., NINDS, 2019; Alzheimer's Association, 2020)

According to the World Health Organization (WHO), currently around 50 million people suffer from some type of diagnosed dementia, of which 60-70% of them report some type or degree of EA. (Alzheimer's Association, 2020; WHO, 2020)

Not only is AD considered a worrying pathology today, but the forecast for medium and long term envisions a severe evolution that will reach 75 million cases in 2030 and 132 million in 2050. (Scheltens et al., 2016; MSCBS, 2019) Specifically in Spain there are more than 700,000 patients currently diagnosed and the forecast is that this number of people affected by AD will double in 2050. (MSCBS, 2019)

Since at the beginning of the s. XX the characteristics of AD were described for the first time (Mauer. K, 2006), scientific research has been, in its beginnings, aimed at alleviating the disease since a pharmacological point of view with modestly effective results (López, 2015) and effects secondary, sometimes unwanted. It therefore seems necessary to address the research and treatment of this disease from a non-pharmacological prism in which music has shown a high degree of efficiency with no adverse effects.

It is at this point that other alternative therapies such as music therapy take center stage. providing notable evidence of the brain activation that occurs, especially when the patient receives sound stimuli. (Peretz, 2005)

The value of music is evident in the numerous cases of musicians (pianists, violinists...) who after a diagnosis of AD begin to experience cognitive and physical deterioration expected, however, this degenerative process does not seem to affect their motor or intellectual to play his instrument even when the disease is in its most severe stage. (Pladdy, 2011)

Thus arises the need to go deeper and discover how music "interferes" in the process. neurodegenerative caused by AD and how it can partner with the patient to, potentially improve your quality of life, strengthen your cognitive reserve, become a useful routine and viable to implement active aging and, ultimately, accompany the patient during evolution of this pathology and, why not?, when the time comes to reverse its advance.

The most common interventions that focus on music as a vehicle to treat AD are aimed at mitigating stress, reducing anxiety and controlling agitation through listening, dancing or singing. (Baird, 2009) However, there are no studies that describe the influence that has to learn to play a musical instrument, in the case of this doctoral thesis: the piano, in the evolution of AD.

The piano is an instrument capable of mobilizing sight, hearing, touch, gross and fine motor skills, perception and emotion activating and making multiple parts of the brain interact (Paxinos, 2004) (hippocampus, cerebral cortex) which, judging by the latest studies, are related to the detection, evolution and treatment of AD.

Hypothesis:

- A therapy based on teaching patients with AD to play the piano may be beneficial for increase your Cognitive Reserve Capacity and improve your Quality of Life.

In this sense, it has been shown that complex mental activity throughout the life cycle can work as a neuroprotective factor in AD. (Valenzuela, 2006)

General objective:

- Analyze the effects of a musical intervention based on piano learning on Alzheimer's patients in León.

Specific objectives:

  • Generate a specific didactic program adapted to Alzheimer's patients based on in acquiring piano skills.
  • Involve the members under study in a prolonged musical experience in time (4 weeks) and value its significance from a therapeutic point of view.
  • Evaluate the evolution of the acquisition of sensory and musical skills in the course of the intervention.
  • Carry out a longitudinal-correlational study of the results obtained pre-post intervention. (Spss)
  • Make an evaluation of the didactic programming and the quality and suitability of the intervention at the end of it to, where appropriate, modify and reorient the aspects susceptible to improvement.

Methodology

The preparation of this study will be structured around three phases. A first phase of documentation on the state of the matter and preparation of the teaching materials that will form part of the resources necessary to carry out the therapeutic intervention. A second phase that will consist of the intervention itself, as well as the collection of the data provided by the control of the different variables subject to study, and finally, a third phase consisting of the evaluation of the data collected, as well as a critical assessment of the pedagogical procedure and, in If applicable, a proposal for an improvement plan for this intervention will be made.

The general methodology of the musical intervention will be an active, participatory, inclusive methodology and integrative, based on project-based learning. It will take into account at all times the uniqueness of each patient, therefore applying personalized attention. In it they will be used musical and extra-musical resources as formative elements, also valuing the Free improvisation as an artistic formula and musical and emotional expression.

The didactic programming will be aimed at developing motor control, developing the connection. Be careful, listen, and will also try to develop the capacity for self-criticism and frustration management, anxiety and emotional control.

The specific methodology of each therapy session will be defined in each of the units that they will make up the didactic programming prepared to carry out the intervention. Having in keep in mind that each session will last 30 minutes, the general methodological dynamic will revolve around this temporary organization:

Activation: 5´Making contact with himspace - teacher - instrument. Development: 20´ Pedagogical intervention. Relaxation: 5´Back to the calm.

Tests and variables:

Age, sex, socio-economic-cultural profile, nutritional status, motor status and other clinical data ofpatient interest. (tension, glucose...)

Cognitive state: (Minimal + (clock, cancellation and Ways))

  • Global
  • Domains: Memory (procedural and declarative. Language, Visuospatial.

Attention.

Visoconstructive, Executive abilities. Behavioral status: (medication) Typology of dementia (inclusion and exclusion criteria in the study) Degree of AD: (Mild moderate, severe, very severe) State of global deterioration.

Functional tests (RDRS-2 Rapid Disability Assessment Scale)

Cognitive evaluation tests: MOCA, WAIS-IV (digits), IST, ZAZZO, Trail Making Test, Clock, Fluency Verbal/categorical.

Neuropsychiatric evaluation test:

  • Behavioral disorders: BEHAVE-AD (Sclan 1996)
  • Frequency and severity of symptoms: Neuropsychiatric Inventory (NPI) (Cummings, 1994):
  • NPI-Q gravity part
  • NPI-Q caregiver stress
  • Evaluation of the severity of the disease (CDS and GDR Scales)
  • Evaluation of the caregiver's burden (Zarit test)

MEDIA AND MATERIAL RESOURCES AVAILABLE

This Initial Research Plan will be presented to the management of ALZHEIMER LEON to make a joint assessment of the suitability and viability of the proposed intervention.

Once approved its execution, the subjects who will make up the sample on which it will be determined will be determined. Will enhance the intervention. A series of tests will be carried out to determine the characteristics of the itself and inclusion/exclusion criteria will be set according to the needs of the study.

Additionally, there will be the departments of interest for the study (Psychology, psychiatry, therapists, social workers...) In addition, this intervention project will be presented to different entities to achieve maximum economic, human and institutional coverage. In this sense, some have been tested private and public institutions such as the Valverde de La Virgen School of Music through its City Council or JJMM-ULE, all of them showing great interest in the study and valuing positively their participation in the research without limiting for the moment the role that each of them they would take in the process.

To carry out the intervention it will be necessary to have a specialist pianist teacher, with a solid musical and pedagogical training and with an additional approach to the particularities of the sample and dynamics of the didactic programming prepared for the study. It will be very important and It is also necessary to have adequate financing to meet the expenses derived from the hiring and training of this professional and other unexpected expenses.

At all times we will try to find appropriate synergies with other entities interested in this study to join forces that give economic viability and dissemination to the project and its results through agreements, collaborations, donations or contributions of any nature.

03

Conditions studied

  • Dementia of Alzheimer Type
  • Dementia
  • Dementia, Vascular
  • Dementia, Mixed
  • Dementia Frontal
  • Dementia With Lewy Bodies
  • Cognitive Decline
  • Neurologic Disorder
  • Neurologic Dysfunction
  • Neurologic Deficits

Keywords

  • Alzheimer
  • Neuropsicology
  • Music
  • Piano
  • Rehabilitación
  • Music Theraphy
04

Who can participate

Ages eligible
50 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Patients in State of global deterioration Levels GDS 2 3 and 4.

Exclusion criteria

Exclusion Criteria:

  • Other patients in GDS groups (not 2, 3 and 4)
  • The selected subject does not cooperate during intervention.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Grupo 0

    Group on which the pianistic intervention will be carried out

    Behavioral: Music therapy based on piano learning

Interventions

  • BehavioralMusic therapy based on piano learning

    The intervention will consist of pianistic training. Patients will receive piano classes adapted to their competence designed to achieve motor, sensory and behavioral control.

06

What researchers measure

Primary outcomes

  1. State of global deterioration

    GDS 1 - 7

    Time frame: Pre-intervention, Post-intervention (after four weeks of intervention), Follow up after 6 month intervention.

  2. Minimental Test

    0-24

    Time frame: Pre-intervention, Post-intervention (after four weeks of intervention), Follow up after 6 month intervention.

  3. RDRS-2 Rapid Disability Assessment Scale

    18-72

    Time frame: Pre-intervention, Post-intervention (after four weeks of intervention), Follow up after 6 month intervention.

  4. MONTREAL COGNITIVE ASSESSMENT (MOCA)

    0-30

    Time frame: Pre-intervention, Post-intervention (after four weeks of intervention), Follow up after 6 month intervention.

  5. WAIS-IV

    0-160

    Time frame: Pre-intervention, Post-intervention (after four weeks of intervention), Follow up after 6 month intervention.

  6. Behavioral disorders: BEHAVE-AD

    Time frame: Pre-intervention, Post-intervention (after four weeks of intervention), Follow up after 6 month intervention.

  7. NPI - CUMMINGS

    0-120

    Time frame: Pre-intervention, Post-intervention (after four weeks of intervention), Follow up after 6 month intervention.

  8. Evaluation of the caregiver's burden (Zarit test)

    0-88

    Time frame: Pre-intervention, Post-intervention (after four weeks of intervention), Follow up after 6 month intervention.

07

Study locations

1 site
  • Universidad de León
    León, Castille and León 24004, Spain
08

References and documents

Publications

  • Alzheimer´s Association. (2020). 2020 Alzheimer´s Disease Facts and Figures. Alzheimer´s & Dementia: The Journal of the Alzheimer Association, 16(3), 391-460. Doi: 10.1002/alz.12068
  • Baird A, Samson S. Memory for music in Alzheimer's disease: unforgettable? Neuropsychol Rev. 2009 Mar;19(1):85-101. doi: 10.1007/s11065-009-9085-2. Epub 2009 Feb 13. PubMed 19214750 ↗
  • Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994 Dec;44(12):2308-14. doi: 10.1212/wnl.44.12.2308. PubMed 7991117 ↗
  • Hanna-Pladdy B, MacKay A. The relation between instrumental musical activity and cognitive aging. Neuropsychology. 2011 May;25(3):378-86. doi: 10.1037/a0021895. PubMed 21463047 ↗
  • López O, Tratamiento farmacológico de la enfermedad de Alzheimer y otras demencias. (2015) Recuperado de: http://www.scielo.edu.uy/scielo.php?pid=S1688-423X2015000200003&script=sci_arttext&tlng=pt
  • Maurer K, Maurer U. Alzheimer. La vida de un médico, la historia de una enfermedad. Madrid: Díaz de Santos; 2006.
  • MSCBS. Ministerio de Sanidad, Consumo y Bienestar Social (2019) Plan integral de Alzheimer y otras Demencias (2019-2023) Recuperado de: https://mscbs.gob.es/profesionales/saludPublica/docs/Plan_Integral_Alzheimer_Octubre_2019.pdf
  • NINDS. National Institute of Neurological Disorders and Stroke. (2019). Recuperado de: https://www.ninds.nih.gov/Disorders/All-Disorders/Alzheimers-Disease Information-Page
  • Paxinos, G. y Mai, J. (2004). The human nervous system. Academic Press, Inc.
  • Peretz I, Zatorre RJ. Brain organization for music processing. Annu Rev Psychol. 2005;56:89-114. doi: 10.1146/annurev.psych.56.091103.070225. PubMed 15709930 ↗
  • Sclan S, Saillon A, Franssen E, et al. The behavior pathology in Alzheimer's disease ratings scale (BEHAVE-AD): reability and analisys of symptom category scores. Int J Geriatr Psychiatry, 1996; 11: 819-830.
  • Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM. Alzheimer's disease. Lancet. 2016 Jul 30;388(10043):505-17. doi: 10.1016/S0140-6736(15)01124-1. Epub 2016 Feb 24. PubMed 26921134 ↗
  • Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL. Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale. J Am Geriatr Soc. 1992 Jun;40(6):549-55. doi: 10.1111/j.1532-5415.1992.tb02101.x. PubMed 1587970 ↗
  • Tariot PN, Mack JL, Patterson MB, Edland SD, Weiner MF, Fillenbaum G, Blazina L, Teri L, Rubin E, Mortimer JA, et al. The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry. 1995 Sep;152(9):1349-57. doi: 10.1176/ajp.152.9.1349. PubMed 7653692 ↗
  • Valenzuela MJ, Sachdev P. Brain reserve and dementia: a systematic review. Psychol Med. 2006 Apr;36(4):441-54. doi: 10.1017/S0033291705006264. Epub 2005 Oct 6. PubMed 16207391 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2024 to primary completion in May 2025, 9 months.

Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's 9 months is below that.

Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: start Jun 2024 → Jul 2024, primary completion Aug 2024 → May 2025 and completion Jun 2025 → May 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 18, 2024
First posted
Apr 22, 2024
StartActual
Jul 26, 2024was Jun 2024
Primary completionActual
May 12, 2025was Aug 2024
CompletionActual
May 12, 2025was Jun 2025
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Nov 13, 2026
Sites
1 site added, 1 site removed
Show site
  • Universidad de León · León, Spain
Show 1 removed
  • Universidad de León · León, Spain
Nov 13, 2026
Start date
Jun 1, 2024→Jul 26, 2024 (actual)
Nov 13, 2026
Primary completion
Aug 1, 2024→May 12, 2025 (actual)
Nov 13, 2026
Study completion
Jun 1, 2025→May 12, 2025 (actual)
Nov 13, 2026
Enrollment
20 (estimated)→5 (actual)
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Not yet recruiting→Completed
    1 site added, 1 site removed
    Show site
    • Universidad de León · León, Spain
    Show 1 removed
    • Universidad de León · León, Spain
    Start date Jun 1, 2024→Jul 26, 2024 (now actual)
    Primary completion Aug 1, 2024→May 12, 2025 (now actual)
    Study completion Jun 1, 2025→May 12, 2025 (now actual)
    Enrollment 20 (estimated)→5 (actual)
    + 5 other changes: identifiers, verification date, description, criteria formatting and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06378372
Lead sponsor
David Franco Castellanos
Collaborators
Jesús Ángel Seco Calvo, Javier Tejada Garcia
Responsible party
David Franco Castellanos (Assistant professor, Universidad de León) — Sponsor-investigator
First posted
Apr 22, 2024
Start date
Jul 26, 2024
Primary completion
May 12, 2025
Completion
May 12, 2025
Last update
Nov 13, 2026

Study contacts

David Franco-Castellanos, Sr
principal investigator · Universidad de León

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion